Cowen And Company, LLC Amicus Therapeutics, Inc. Call Options Transaction History

Cowen And Company, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 09, 2023	BUY	$9.89 - $12.7 $75,164 - $96,520	7,600 New	7,600 $92,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $432,630 - $586,080	-49,500 Reduced 40.88%	71,600 $27,000
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $344,045 - $423,440	-39,500 Reduced 24.6%	121,100 $48,000
Q1 2021 May 04, 2021	BUY	$9.2 - $23.86 $598,000 - $1.55 Million	65,000 Added 67.99%	160,600 $101,000
Q4 2020 Feb 08, 2021	BUY	$13.47 - $24.89 $1.29 Million - $2.38 Million	95,600 New	95,600 $154,000
Q3 2020 Nov 03, 2020	SELL	$12.89 - $15.89 $257,800 - $317,800	-20,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $177,200 - $313,800	20,000 New	20,000 $68,000
Q4 2019 Feb 11, 2020	SELL	$7.48 - $10.75 $245,344 - $352,600	-32,800 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $263,056 - $434,600	32,800 New	32,800 $1,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.